Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
17.68
-0.28 (-1.56%)
Oct 8, 2025, 4:00 PM EDT - Market closed
Healthcare Realty Trust Stock Forecast
Stock Price Forecast
The 6 analysts that cover Healthcare Realty Trust stock have a consensus rating of "Hold" and an average price target of $19.17, which forecasts a 8.43% increase in the stock price over the next year. The lowest target is $16 and the highest is $23.
Price Target: $19.17 (+8.43%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Healthcare Realty Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 1 | 2 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 2 | 2 | 2 | 2 | 3 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Initiates $19 | Hold | Initiates | $19 | +7.47% | Oct 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $23 | Buy | Initiates | $23 | +30.09% | Oct 1, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +13.12% | Sep 29, 2025 |
| Raymond James | Raymond James | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Sep 15, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +13.12% | Sep 10, 2025 |
Financial Forecast
Revenue This Year
1.20B
from 1.27B
Decreased by -5.06%
Revenue Next Year
1.21B
from 1.20B
Increased by 0.17%
EPS This Year
-0.43
from -1.81
EPS Next Year
-0.27
from -0.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.3B | 1.3B | ||
| Avg | 1.2B | 1.2B | ||
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.3% | 7.1% | ||
| Avg | -5.1% | 0.2% | ||
| Low | -12.8% | -12.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.09 | -0.19 | |
| Avg | -0.43 | -0.27 | |
| Low | -0.70 | -0.42 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.